Use of DHEA or precursors or metabolic derivatives thereof...

Details Use of DHEA or precursors or metabolic derivatives thereof... Use of DHEA or precursors or metabolic derivatives thereof...

2008-04-01

2008-04-01

Wang, Shengjun (Department: 1617)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

C514S169000, C514S177000, C514S182000, C424S401000, C424S059000

Reexamination Certificate

active

09686997

ABSTRACT:
The use of DHEA or at least one of its biological precursors or of its metabolic derivatives in or for the manufacture of a composition for topical application to the skin, as a pigmentation regulator for the skin or its superficial growths, especially as a depigmenting and/or bleaching agent for the skin, in particular in the treatment of pigmentation marks, and as a pro-pigmenting agent for superficial body growths.

REFERENCES:
patent: 4316033 (1982-02-01), Ching
patent: 4328346 (1982-05-01), Chung et al.
patent: 4496556 (1985-01-01), Orentreich
patent: 4542129 (1985-09-01), Orentreich
patent: 4617390 (1986-10-01), Hoppe et al.
patent: 5607692 (1997-03-01), Ribier et al.
patent: 5670487 (1997-09-01), Grollier et al.
patent: 5776438 (1998-07-01), Tokue et al.
patent: 5824671 (1998-10-01), Labrie
patent: 5869090 (1999-02-01), Rosenbuam
patent: 5900242 (1999-05-01), Breton et al.
patent: 5942531 (1999-08-01), Diaz et al.
patent: 5989568 (1999-11-01), Breton et al.
patent: 6149933 (2000-11-01), Nelson
patent: 6486147 (2002-11-01), Baldo et al.
patent: EP 0087098 (1983-08-01), None
patent: 0389377 (1990-09-01), None
patent: 0517104 (1992-12-01), None
patent: 0570838 (1993-11-01), None
patent: 0655453 (1995-05-01), None
patent: 0 723 775 (1996-07-01), None
patent: 0796851 (1997-09-01), None
patent: 2528420 (1982-06-01), None
patent: 2581542 (1986-11-01), None
patent: EP 0354145 (1990-02-01), None
patent: 2639347 (1990-05-01), None
patent: EP 0392883 (1990-10-01), None
patent: 2657351 (1991-07-01), None
patent: EP 0524109 (1993-01-01), None
patent: EP 0723775 (1996-07-01), None
patent: EP 0738510 (1996-10-01), None
patent: EP 0756866 (1997-02-01), None
patent: EP 0660701 (1997-05-01), None
patent: 2 760 362 (1998-09-01), None
patent: EP 0875495 (1998-11-01), None
patent: EP 0895779 (1999-02-01), None
patent: 2 777 181 (1999-10-01), None
patent: 2 777 181 (1999-10-01), None
patent: 60142908 (1985-07-01), None
patent: 60 161912 (1985-08-01), None
patent: 60161912 (1985-08-01), None
patent: 07 196467 (1995-08-01), None
patent: 7196467 (1995-08-01), None
patent: WO 94/06404 (1994-03-01), None
patent: WO 97 10255 (1997-03-01), None
patent: WO 97/12597 (1997-04-01), None
patent: WO 97/13500 (1997-04-01), None
patent: WO 98/35973 (1998-08-01), None
patent: WO 99/10318 (1999-03-01), None
patent: WO 99/22707 (1999-05-01), None
patent: WO 99/32077 (1999-07-01), None
Hadley et al., “Hormonal control of melanogenesis,” Pigm. and Pigm. Disord., ed. Norman Levine, 1993, pp. 95-114.
E. E. Baulieu et al,Dehydroepiandrosterone(DHEA), DHEA sulfate, and aging: Contribution of the DHEAge Study to a Sociobiomedical Issue, PNAS, Apr. 11, 2000, vol. 97, No. 8, pp. 4279-4284, XP002141516.
Shinchi Kawai, et al,Dehydroepiandrosterone Inhibits B16 Mouse Melanoma Cell Growth By Induction or Differentiation,Chemical Abstracts, vol. 123, No. 7, Aug. 14, 1995, XP-002141517.
Patent Abstracts of Japan, vol. 1995, No. 11, Dec. 26, 1995, JP07195467.
Patent Abstracts of Japan, vol. 009, No. 331, Dec. 25, 1985, JP60161912.
Chemical Abstracts, vol. 123, No. 7, Aug. 14, 1995, Columbus, OH, Abstract No. 75142q. Shinichi Kawai, et al.: “Dehydroepiandrosterone Inhibits B16 Mouse Melanoma Cell Growth By Induction or Differentiation” XP002141517.
Anticancer Research, vol. 15, No. 2, 1995, “Dehydroepiandrosterone Inhibits B16 Mouse Melanoma Cell Growth By Induction or Differentiation”pp. 427-432.
E.E., Baulieu, et al.: “Dehydroepiandrosterone (DHEA), DHEA Sulfate and Aging: Contribution of the DHEAge Study to a Sociobiomedical Issue” Proceedings of the National Academy of Sciences of USA, vol. 97, No. 8, Apr. 11, 2000, pp. 4279-4284, XP002141516.
National Academy of Science, U.S., ISSN: 0027-8424, “Life In A Ligand Sphere”, pp. 4283-4287, May 1994.

Affiliated with

Also associated with

Rating

Use of DHEA or precursors or metabolic derivatives thereof... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of DHEA or precursors or metabolic derivatives thereof..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of DHEA or precursors or metabolic derivatives thereof... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3917125